跳轉至內容
Merck
全部照片(1)

文件

146064

Sigma-Aldrich

β-丙氨酸

99%, suitable for ligand binding assays

同義詞:

β-Ala, 3-氨基丙酸

登入查看組織和合約定價


About This Item

線性公式:
NH2CH2CH2COOH
CAS號碼:
分子量::
89.09
Beilstein:
906793
EC號碼:
MDL號碼:
分類程式碼代碼:
12352209
eCl@ss:
39030936
PubChem物質ID:
NACRES:
NA.26

product name

β-丙氨酸, 99%

化驗

99%

形狀

powder, crystals or granules

技術

ligand binding assay: suitable

顏色

white

mp

202 °C (dec.) (lit.)

應用

peptide synthesis

SMILES 字串

NCCC(O)=O

InChI

1S/C3H7NO2/c4-2-1-3(5)6/h1-2,4H2,(H,5,6)

InChI 密鑰

UCMIRNVEIXFBKS-UHFFFAOYSA-N

尋找類似的產品? 前往 產品比較指南

應用

β-丙氨酸被用作MAS孤儿相关受体的配体。它还用于某些酵母菌株的培养基中以检测β-丙氨酸营养缺陷体。

生化/生理作用

β丙氨酸是一种 β− 氨基酸,是泛酸的组分,是组氨酰基抗氧化剂二肽肌肽和鹅肌肽生物合成中的限速氨基酸。内源性 β-氨基酸,是甘氨酸受体的非选择性激动剂和G蛋白偶联孤儿受体TGR7(MrgD)的配体。 β-丙氨酸通量通过维持海洋生物、植入前小鼠胚胎和暴露于缺氧应激的哺乳动物细胞的渗透稳定性而发挥细胞保护作用。

儲存類別代碼

11 - Combustible Solids

水污染物質分類(WGK)

WGK 1

閃點(°F)

Not applicable

閃點(°C)

Not applicable

個人防護裝備

Eyeshields, Gloves, type N95 (US)


分析證明 (COA)

輸入產品批次/批號來搜索 分析證明 (COA)。在產品’s標籤上找到批次和批號,寫有 ‘Lot’或‘Batch’.。

已經擁有該產品?

您可以在文件庫中找到最近購買的產品相關文件。

存取文件庫

Saccharomyces cerevisiae is capable of de Novo pantothenic acid biosynthesis involving a novel pathway of beta-alanine production from spermine.
White WH
The Journal of Biological Chemistry, 276(14), 10794-10800 (2001)
The orphan G protein-coupled receptor GPR139 is activated by the peptides: Adrenocorticotropic hormone (ACTH), a-, and ?-melanocyte stimulating hormone (a-MSH, and ?-MSH), and the conserved core motif HFRW.
N?hr AC, et al.
Neurochemistry International, 102, 105-113 (2017)
Ramin Artang et al.
The American journal of cardiology, 112(12), 1973-1979 (2013-10-01)
Dabigatran has been associated with greater risk of myocardial infarction (MI) than warfarin. It is unknown whether the increased risk is unique to dabigatran, an adverse effect shared by other oral direct thrombin inhibitors (DTIs), or the result of a
Robert G Hart et al.
The Canadian journal of cardiology, 29(7 Suppl), S71-S78 (2013-06-29)
Chronic kidney disease (CKD) is prevalent in elderly patients with atrial fibrillation and is an independent risk factor for stroke. Warfarin anticoagulation is efficacious for stroke prevention in atrial fibrillation patients with moderate CKD (stage III, estimated glomerular filtration rate
Ammar Majeed et al.
Circulation, 128(21), 2325-2332 (2013-10-02)
The aim of this study was to compare the management and prognosis of major bleeding in patients treated with dabigatran or warfarin. Two independent investigators reviewed bleeding reports from 1034 individuals with 1121 major bleeds enrolled in 5 phase III

我們的科學家團隊在所有研究領域都有豐富的經驗,包括生命科學、材料科學、化學合成、色譜、分析等.

聯絡技術服務